Cargando…

Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis

BACKGROUND: Despite the evidence that phosphate binder (PB) is associated with improved outcomes many hemodialysis patients do not adhere to prescribed PB regimen. Therefore, barriers to PB adherence should be identified and eliminated. The purpose of this study was to evaluate PB adherence among he...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Maria Tereza Silveira, Silva, Luciana Ferreira, Kraychete, Angiolina, Reis, Dandara, Dias, Lidiane, Schnitman, Gabriel, Oliveira, Lívia, Lopes, Gildete Barreto, Lopes, Antonio Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851130/
https://www.ncbi.nlm.nih.gov/pubmed/24090377
http://dx.doi.org/10.1186/1471-2369-14-208
_version_ 1782294231120871424
author Martins, Maria Tereza Silveira
Silva, Luciana Ferreira
Kraychete, Angiolina
Reis, Dandara
Dias, Lidiane
Schnitman, Gabriel
Oliveira, Lívia
Lopes, Gildete Barreto
Lopes, Antonio Alberto
author_facet Martins, Maria Tereza Silveira
Silva, Luciana Ferreira
Kraychete, Angiolina
Reis, Dandara
Dias, Lidiane
Schnitman, Gabriel
Oliveira, Lívia
Lopes, Gildete Barreto
Lopes, Antonio Alberto
author_sort Martins, Maria Tereza Silveira
collection PubMed
description BACKGROUND: Despite the evidence that phosphate binder (PB) is associated with improved outcomes many hemodialysis patients do not adhere to prescribed PB regimen. Therefore, barriers to PB adherence should be identified and eliminated. The purpose of this study was to evaluate PB adherence among hemodialysis patients and to explore potentially modifiable factors associated with low PB adherence. METHODS: A cross-sectional study (502 patients) was performed in four dialysis units in Salvador, Brazil, using data from the second phase of the Prospective Study of the Prognosis of Chronic Hemodialysis Patients (PROHEMO). Patients were categorized as adherent or non-adherent to PB based on their responses to a semi-structured questionnaire. RESULTS: Non-adherence to PB was observed for 65.7% of the patients. After adjustments for numerous covariates, cerebrovascular disease (odds ratio (OR), 3.30; 95% confidence interval (CI), 1.03-10.61), higher PTH (OR per each 300 pg/mL, 1.14; 95% CI, 1.01-1.28), lack of comprehension of the appropriate time to use PB (OR, 7.09; 95% CI, 2.10-23.95) and stopping PB use after feeling better (OR, 4.54; 95% CI, 1.45-14.25) or feeling worse (OR, 11.04; 95% CI, 1.79- 68.03) were significantly associated with PB non-adherence. By contrast, the adjusted odds of PB non-adherence were lower for patients with more years on dialysis (OR by each 2 years, 0.87; 95% CI, 0.80-0.95), with serum phosphorus above 5.5 mg/dL (OR, 0.53; 95% CI 0.34-0.82), who referred that were encouraged by the dialysis staff to be independent (OR, 0.52; 95% CI 0.30-0.90), and reported that the nephrologist explained how PB should be used (OR, 0.20; 95% CI 0.05-0.73). CONCLUSION: The results of the present study are encouraging by showing evidence that improvement in the care provided by the dialysis staff and the attending nephrologist may play an important role in reducing the high prevalence of non-adherence to PB in maintenance hemodialysis patients. A new questionnaire is presented and may help to evaluate systematically the patients regarding PB adherence in hemodialysis setting.
format Online
Article
Text
id pubmed-3851130
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38511302013-12-05 Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis Martins, Maria Tereza Silveira Silva, Luciana Ferreira Kraychete, Angiolina Reis, Dandara Dias, Lidiane Schnitman, Gabriel Oliveira, Lívia Lopes, Gildete Barreto Lopes, Antonio Alberto BMC Nephrol Research Article BACKGROUND: Despite the evidence that phosphate binder (PB) is associated with improved outcomes many hemodialysis patients do not adhere to prescribed PB regimen. Therefore, barriers to PB adherence should be identified and eliminated. The purpose of this study was to evaluate PB adherence among hemodialysis patients and to explore potentially modifiable factors associated with low PB adherence. METHODS: A cross-sectional study (502 patients) was performed in four dialysis units in Salvador, Brazil, using data from the second phase of the Prospective Study of the Prognosis of Chronic Hemodialysis Patients (PROHEMO). Patients were categorized as adherent or non-adherent to PB based on their responses to a semi-structured questionnaire. RESULTS: Non-adherence to PB was observed for 65.7% of the patients. After adjustments for numerous covariates, cerebrovascular disease (odds ratio (OR), 3.30; 95% confidence interval (CI), 1.03-10.61), higher PTH (OR per each 300 pg/mL, 1.14; 95% CI, 1.01-1.28), lack of comprehension of the appropriate time to use PB (OR, 7.09; 95% CI, 2.10-23.95) and stopping PB use after feeling better (OR, 4.54; 95% CI, 1.45-14.25) or feeling worse (OR, 11.04; 95% CI, 1.79- 68.03) were significantly associated with PB non-adherence. By contrast, the adjusted odds of PB non-adherence were lower for patients with more years on dialysis (OR by each 2 years, 0.87; 95% CI, 0.80-0.95), with serum phosphorus above 5.5 mg/dL (OR, 0.53; 95% CI 0.34-0.82), who referred that were encouraged by the dialysis staff to be independent (OR, 0.52; 95% CI 0.30-0.90), and reported that the nephrologist explained how PB should be used (OR, 0.20; 95% CI 0.05-0.73). CONCLUSION: The results of the present study are encouraging by showing evidence that improvement in the care provided by the dialysis staff and the attending nephrologist may play an important role in reducing the high prevalence of non-adherence to PB in maintenance hemodialysis patients. A new questionnaire is presented and may help to evaluate systematically the patients regarding PB adherence in hemodialysis setting. BioMed Central 2013-10-03 /pmc/articles/PMC3851130/ /pubmed/24090377 http://dx.doi.org/10.1186/1471-2369-14-208 Text en Copyright © 2013 Martins et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Martins, Maria Tereza Silveira
Silva, Luciana Ferreira
Kraychete, Angiolina
Reis, Dandara
Dias, Lidiane
Schnitman, Gabriel
Oliveira, Lívia
Lopes, Gildete Barreto
Lopes, Antonio Alberto
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title_full Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title_fullStr Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title_full_unstemmed Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title_short Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
title_sort potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851130/
https://www.ncbi.nlm.nih.gov/pubmed/24090377
http://dx.doi.org/10.1186/1471-2369-14-208
work_keys_str_mv AT martinsmariaterezasilveira potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT silvalucianaferreira potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT kraycheteangiolina potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT reisdandara potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT diaslidiane potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT schnitmangabriel potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT oliveiralivia potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT lopesgildetebarreto potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis
AT lopesantonioalberto potentiallymodifiablefactorsassociatedwithnonadherencetophosphatebinderuseinpatientsonhemodialysis